RE: DIVIDED DOSE I-131 THYROID TREATMENTS

["Burba, Michael (BURBAMJ)" <BURBAMJ@UCMAIL.UC.EDU>]

We started using the release procedures of Reg Guide 8.39 as soon as they
were authorized on May 29, 1997. The new criteria eliminated a lot of work
and expense for I-131 patients. For brachytherapy there was an increase in
requirements, specifically, written instructions and the lower limits
conflict occasionally with permanent I-125 brain implants.  The release
limit went from 5 mrem at one meter to 1 mrem. Also, for
radiopharmaceuticals, more attention is required for breast-feeding
patients. Overall, the change was positive for our program.

Mike Burba
Asst RSO
University of Cincinnati
Michael.Burba@uc.edu
(513)558-4110  FAX (9905)

> -----Original Message-----
> From:	SMarlette [SMTP:SMarlette@aol.com]
> Sent:	Monday, May 04, 1998 7:28 PM
> To:	Multiple recipients of list
> Subject:	Re: DIVIDED DOSE I-131 THYROID TREATMENTS
> 
> What is the opinion out there of the use of new Reg Guide 8.39 to give
> much
> higher doses without hospitalization?  Are you using it?